TERN - Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram Former Chief Executive Officer | Benzinga
FOSTER CITY, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious oncologic and metabolic diseases, today announced that Senthil Sundaram, the Company's recently retired Chief Executive Officer, passed away on November 22, 2023, following his battle with cancer.
"It is with great sadness we announce Sen's passing. Sen was a visionary leader who inspired us all with his passion, dedication, and unwavering commitment to improving patient care through scientific innovation. He will be deeply missed by everyone who had the privilege of knowing him. Our thoughts and prayers are with his family and loved ones during this difficult time," said David Fellows, Chairman of the Board of Terns.
"Sen's legacy lives on through the Peritoneal Cancer Foundation (PCF), a charity he formed to support research for and raise awareness of peritoneal cancer, which remains both misunderstood and ...